Marshall Wace North America’s TransAlta TAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$139K Sell
13,108
-354,527
-96% -$3.55M ﹤0.01% 1347
2021
Q2
$3.67M Buy
+367,635
New +$3.55M 0.02% 643
2021
Q1
Sell
-615,347
Closed -$4.67M 1772
2020
Q4
$4.67M Sell
615,347
-143,997
-19% -$962K 0.02% 558
2020
Q3
$4.66M Sell
759,344
-248,689
-25% -$1.56M 0.03% 412
2020
Q2
$5.96M Sell
1,008,033
-540,467
-35% -$3.11M 0.04% 345
2020
Q1
$8.01M Buy
1,548,500
+1,110,217
+253% +$7.53M 0.06% 247
2019
Q4
$3.14M Buy
438,283
+371,110
+552% +$2.41M 0.02% 476
2019
Q3
$437K Buy
+67,173
New +$426K ﹤0.01% 835
2019
Q1
Sell
-8,431
Closed -$34K 1885
2018
Q4
$34K Buy
+8,431
New +$44.1K ﹤0.01% 1339
2018
Q3
Sell
-230,101
Closed -$1.16M 1356
2018
Q2
$1.16M Buy
230,101
+128,459
+126% +$668K 0.01% 898
2018
Q1
$550K Buy
+101,642
New +$561K ﹤0.01% 1131

Other funds holding TAC

Marshall Wace North America's TAC Position: Q3 2021 in Review

Marshall Wace North America reduced its TransAlta (TAC) stake by 96% in Q3 2021, selling an estimated $3.55M and leaving 13,108 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Marshall Wace North America first reported a position in TAC in Q1 2018 and has held it in 11 quarters since. The position peaked at $8.01M in Q1 2020. 93 funds tracked by Wall St. Rank hold TAC as of Q3 2021.

  • Marshall Wace North America held 13,108 shares of TransAlta worth $139K as of Q3 2021.
  • Marshall Wace North America sold 354,527 TransAlta shares in Q3 2021, an estimated $3.55M.
  • TransAlta made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1347 holding.
  • Marshall Wace North America first reported a position in TransAlta in Q1 2018 and has held it in 11 quarters since.
  • Marshall Wace North America's TransAlta position peaked at $8.01M in Q1 2020.
  • 93 funds tracked by Wall St. Rank held TransAlta as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.